Compounds > nortriptyline

nortriptyline and desloratadine

nortriptyline has been researched along with desloratadine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalvie, D; Loi, CM; Smith, DA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Miller, SD; Padval, MV; Podojil, JR1
Bastiancich, C; De Backer, L; De Smedt, SC; Joris, F; Raemdonck, K; Van de Vyver, T1

Reviews

1 review(s) available for nortriptyline and desloratadine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for nortriptyline and desloratadine

ArticleYear
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.
    Cellular immunology, 2011, Volume: 270, Issue:2

    Topics: Animals; Central Nervous System; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; Interleukin-4; Loratadine; Mice; Mice, Transgenic; Myelin Proteolipid Protein; Nortriptyline; Peptide Fragments; T-Lymphocytes

2011
Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 01-10, Volume: 269

    Topics: Adjuvants, Pharmaceutic; Carvedilol; Cell Cycle Proteins; Cell Line, Tumor; Dextrans; Fluorescein-5-isothiocyanate; Gels; Green Fluorescent Proteins; Humans; Loratadine; Lysosomes; Nanoparticles; Nortriptyline; Oligonucleotides; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Small Interfering; Salmeterol Xinafoate; Transfection

2018